Drawing for BIO-PLATFORM

USPTO serial 75837005

BIO-PLATFORM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RUPP, BRIAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIO-PLATFORM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Immunolumanescent diagnostics, namely, chemical, biological, biochemical, immunological and microbilogical reagents and diagnostic preparations for scientific and commercial purposes; chemical reagents for immunolumanescent diagnostics used in scientific research; immunodiagnostic assay test kits consisting primarily of reagents and other chemicals which detect immune complexes in body fluids for scientific and research use; microbeads for standardization of flow cytometers for laboratory studies in the fields of antibodies and cell biology; reagents, namely, buffer solutions used in molescular biological laboratories; chemicals for electrophoresis, namely, buffer solutions used in molescular biological laboratories; chemicals for electrophoresis, namely, buffer solutions; chemicals, namely, buffer solutions used in the chemical, medical pharmaceutical, and food industries; diagnostic reagents for scientific or research use, namely, buffer solution; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; cell lines for scientific, laboratory or medical research; virus strains for scientific, laboratory or medical researchACTIVE—
005Diagnostic test kits comprised primarily of immunolumanescent diagnostics; diagnostic preparations for clinical and medical laboratory use, namely, immunolumanescent diagnostics; clinical diagnostic reagent kits consisting of immunodiagnostic assays for use in-vitro testing, microbeads for clinical and diagnostic studies in the fields of antibodies and cell biology; medical diagnostic reagents, namely, buffer solution; diagnostic reagents for clinical or medical laboratory use, namely, buffer solution; cell lines for medical or clinical useACTIVE—
042Biological product development; laboratory research in the field of biological productionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2004MAILPAPER RECEIVED—
Oct 11, 2002ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 27, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 4, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 15, 2001NPUBNOTICE OF PUBLICATION—
Apr 12, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 5, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance